WATSON 405 (Lisinopril 2.5 mg)
Pill imprint WATSON 405 has been identified as Lisinopril 2.5 mg.
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; migraine prevention; coronary artery disease; heart failure (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 405 (Lisinopril 2.5 mg)
- 2.5 mg
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dihydrate dibasic